Coconut Oil and Cardiovascular Disease Risk

Curr Atheroscler Rep. 2023 May;25(5):231-236. doi: 10.1007/s11883-023-01098-y. Epub 2023 Mar 27.

Abstract

Purpose of review: This narrative review summarizes the current peer-reviewed literature and mechanisms surrounding the cardiovascular health impact of coconut oil.

Recent findings: No randomized controlled trials (RCTs) and/or prospective cohort studies have investigated the effect or association of coconut oil with cardiovascular disease. Evidence from RCTs indicated that coconut oil seems to have less detrimental effects on total and LDL-cholesterol compared to butter, but not compared to cis-unsaturated vegetable oils, such as safflower, sunflower, or canola oil. The isocaloric replacement (by 1% of energy intake) of carbohydrates with lauric acid (the predominant fatty acid in coconut oil) increased total cholesterol by 0.029 mmol/L (95% CI: 0.014; 0.045), LDL-cholesterol by 0.017 mmol/L (0.003; 0.031), and HDL-cholesterol by 0.019 mmol/L (0.016; 0.023). The current evidence from shorter term RCTs suggests that replacement of coconut oil with cis-unsaturated oils lowers total and LDL-cholesterol, whereas for the association between coconut oil intake and cardiovascular disease, less evidence is available.

Keywords: Cardiovascular; Coconut oil; Evidence; Meta-analyses.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiovascular Diseases* / epidemiology
  • Cholesterol, LDL
  • Coconut Oil
  • Dietary Fats*
  • Humans
  • Plant Oils / adverse effects
  • Triglycerides

Substances

  • Coconut Oil
  • Dietary Fats
  • Plant Oils
  • Cholesterol, LDL
  • Triglycerides